BAL fluid 8-isoprostane concentrations in eosinophilic bronchitis and asthma

Journal of Asthma

Volumn 46, Issue 7, 2009, Pages 712-715

  Xie, Jiaxing ^a   Zhang, Qingling ^a   Zhong, Nanshan ^a   Lai, Kefang ^a,b  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

8 epi prostaglandin F2alpha; Asthma; Eosinophilic bronchitis; Oxidative stress

Indexed keywords

8 ISOPROSTANE;

ADULT; ARTICLE; ASTHMA; BRONCHITIS; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; ENZYME IMMUNOASSAY; EOSINOPHIL; EOSINOPHIL COUNT; EOSINOPHILIC BRONCHITIS; FEMALE; HUMAN; HUMAN CELL; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MALE; NEUTROPHIL; OXIDATIVE STRESS; SPUTUM ANALYSIS;

ADULT; ASTHMA; BRONCHITIS; BRONCHOALVEOLAR LAVAGE FLUID; DINOPROST; EOSINOPHILIA; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; OXIDATIVE STRESS; SPUTUM;

EID: 70249115553     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900903067879     Document Type: Article

References (38)

1. Eder W, Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355:2226-2235.
2. Brightling CE, Ward R, Goh KL, Wardlaw AJ, Pavord ID. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999; 160:406-410.
3. Brightling CE, Symon FA, Birring SS, Bradding P, Wardlaw AJ, Pavord ID. Comparison of airway immunopathology of eosinophilic bronchitis and asthma. Thorax 2003; 58:528-532.
4. Lai KF, Chen RC, Liu CL, Luo W, Zhong SQ, He MZ, Li DR, Zhong NS. Etiology and a diagnostic protocol for patients with chronic cough. Zhonghua Jie He He Hu Xi Za Zhi 2006; 29:96-99.
5. Brightling CE, Ward R, Woltmann G, Bradding P, Sheller JR, Dworski R, Pavord ID. Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. Am J Respir Crit Care Med 2000; 162:878-882.
6. Gibson PG, Zlatic K, Scott J, Sewell W, Woolley K, Saltos N. Chronic cough resembles asthma with IL-5 and granulocyte macrophage colony stimulating factor gene expression in bronchoalveolar cells. J Allergy Clin Immunol 1998; 101:320-326.
7. Sastre B, Fernández-Nieto M, Mollá R, López E, Lahoz C, Sastre J, del Pozo V, Quirce S. Increased prostaglandin E2 levels in the airway of patients with eosinophilic bronchitis. Allergy 2008; 63:58-66.
8. Berry MA, Parker D, Neale N, Woodman L, Morgan A, Monk P, Bradding P, Wardlaw AJ, Pavord ID, Brightling CE. Sputum and bronchial submucosal IL-13 expression in asthma and eosinophilic bronchitis. J Allergy Clin Immunol 2004; 114:1106-1109.
9. Park SW, Jangm HK, An MH, Min JW, Jang AS, Lee JH, Park CS. Interleukin-13 and interleukin-5 in induced sputum of eosinophilic bronchitis comparison with asthma. Chest 2005; 128:1921-1927.
10. Caramori G, Papi A. Oxidants and asthma. Thorax 2004; 59:170-173.
11. Roberts LJ, Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28:505-513.
12. Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci 2002; 23:360-366.
13. Morrow JD, Roberts LJ. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med 2002; 166:S25-30.
14. Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Lipid perox-idation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids 2000; 35:967-974.
15. Baraldi E, Ghiro L, Piovan V, Carraro S, Ciabattoni G, Barnes PJ, Montuschi P. Increased exhaled 8-isoprostane in childhood asthma. Chest 2003; 124:25-31.
16. Dworski R, Murray JJ, Roberts LJ 2nd, Oates JA, Morrow JD, Fisher L, Sheller JR. Allergen-induced synthesis of F2-isoprostanes in atopic asthmatics. Am J Respir Crit Care Med 1999; 160:1947-1951.
17. Kawikova I, Barnes PJ, Takahashi T, Tadjkarimi S, Yacoub MH, Belvisi MG. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am J Respir Crit Care Med 1996; 153: 590-596.
18. Santiago Quirce. Eosinophilic bronchitis in the workplace. Current Opinion in Allergy and Clinical Immunology 2004; 4:87-91.
19. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244.
20. Global strategy for asthma management and prevention. Update from NHLB/WHO Workshop Report 1995. GINA, Revised 2002, NIH Publication No. 02-3659, 2002.
21. Brightling CE. Chronic cough due to nonasthmatic eosinophilic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:116S-121S.
22. Sovijärvi AR, Malmberg LP, Reinikainen K, Rytilä P, Poppius H. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material. Chest 1993; 104:164-170.
23. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, Dolovich J. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25-29.
24. Jackson AS, Sandrini A, Campbell C, Chow S, Thomas PS, Yates DH. Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage. Am J Respir Crit Care Med 2007; 175:222-227.
25. Reynolds HY. Use of bronchoalveolar lavage in humans-past necessity and future imperative. Lung 2000; 178:271-293.
26. Talati M, Meyrick B, Peebles RS Jr, Davies SS, Dworski R, Mernaugh R, Mitchell D, Boothby M, Roberts LJ 2nd, Sheller JR. Oxidant stress modulates murine allergic airway responses. Free Radic Biol Med 2006; 40:1210-1219.
27. Katsumata U, Miura M, Ichinose M, Kimura K, Takahashi T, Inoue H, Takishima T. Oxygen radicals produce airway constriction and hyperres-ponsiveness in anesthetized cats. Am Rev Respir Dis 1990; 141:1158-1161.
28. Weiss EB, Bellino JR. Leukotriene-associated toxic oxygen metabolites induces airway hyperreactivity. Chest 1986; 89:709-716.
29. Rhoden KJ, Barnes PJ. Effect of hydrogen peroxide on guinea-pig tracheal muscle in vitro: role of cyclooxygenase and airway epithelium. Br J Pharmacol 1989; 98:325-330.
30. Barnes BJ. Reactive oxygen species and airway inflammation. Free Radic Biol Med 1990; 9:235-243.
31. Kanazawa H, Kurihara N, Hirata K, Takeda T. The role of free radicals in airway obstruction in asthmatic patients. Chest 1991; 100:1319-1322.
32. Sedgwick JB, Geiger KM, Busse WW. Superoxide generation by hypodense eosinophils from patients with asthma. Am Rev Respir Dis 1990; 142:120-125.
33. Joseph BZ, Routes JM, Borish L. Activities of superoxide dismutases and NADPH oxidase in neutrophils obtained from asthmatic and normal donors. Inflammation 1993; 17:361-367.
34. Wood LG, Gibson PG, Garg ML. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 2003; 21:177-186.
35. Mortaz E, Redegeld FA, Nijkamp FP, Engels F. Aspirin induces the production of the inflammatory mediator 8-epi-PGF in mast cells. Eur J Pharmacol 2006; 543:190-193.
36. Janssen LJ, Catalli A, Helli P. The pulmonary biology of isoprostanes. Antioxid Redox Signal 2005; 7:244-255.
37. Held HD, Uhlig S. Mechanisms of endotoxin-induced airway and pulmonary vascular hyperreactivity in mice. Am J Respir Crit Care Med 2000; 162:1547-1552.
38. Okazawa A, Kawikova I, Cui ZH, et al. 8-epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo. Am J Respir Crit Care Med 1997; 155:436-441.